From June 2021, pharmacists will have another option for the non-prescription management of sleep disorder in the target population, melatonin. This second of two articles by pharmacist David Pache focuses on what pharmacists should know about melatonin. It discusses the role of melatonin within the context of community pharmacy, issues that pharmacists need to consider
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.